Cart
sales@molnova.com
AZD3229
CAS No. 2248003-60-1
AZD3229( AZD-3229 | AZD 3229 )
Catalog No. M13614 CAS No. 2248003-60-1
AZD3229 (AZD-3229) is a potent, pan-KIT mutant inhibitor with potent single digit nM growth inhibition against a diverse panel of mutant KIT driven Ba/F3 cell lines (GI50=1-50 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 133 | In Stock |
|
| 10MG | 215 | In Stock |
|
| 25MG | 390 | In Stock |
|
| 50MG | 574 | In Stock |
|
| 100MG | 803 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAZD3229
-
NoteResearch use only, not for human use.
-
Brief DescriptionAZD3229 (AZD-3229) is a potent, pan-KIT mutant inhibitor with potent single digit nM growth inhibition against a diverse panel of mutant KIT driven Ba/F3 cell lines (GI50=1-50 nM).
-
DescriptionAZD3229 (AZD-3229) is a potent, pan-KIT mutant inhibitor with potent single digit nM growth inhibition against a diverse panel of mutant KIT driven Ba/F3 cell lines (GI50=1-50 nM); shows good margin to KDR-driven effects, also inhibits PDGFR mutants (Tel-PDGFRα, Tel-PDGFRβ, V561D/D842V).
-
In Vitro——
-
In Vivo——
-
SynonymsAZD-3229 | AZD 3229
-
PathwayAngiogenesis
-
Targetc-Kit
-
RecptorKit
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2248003-60-1
-
Formula Weight479.516
-
Molecular FormulaC24H26FN7O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 95 mg/mL (198.12 mM); Water: Insoluble （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(NC1=CC=C(NC2=C3C(F)=CC(OCCOC)=CC3=NC=N2)C=C1)CN4N=NC(C(C)C)=C4
-
Chemical NameN-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]-amino}phenyl)-2-[4-(propan-2-yl)-1H-1,2,3-triazol-1-yl]-acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kettle JG, et al. J Med Chem. 2018 Sep 24. doi: 10.1021/acs.jmedchem.8b00938.
molnova catalog
related products
-
OSI-930
A potent, orally active, dual inhibitor of c-Kit and VEGFR-2 (KDR) with IC50 of 15 nM and 9 nM, respectively.
-
M4205
M4205 is an inhibitor of c-Kit exhibiting high activity on c-Kit mutations in exons 11, 13, 17.
-
DCC-2618
DCC-2618 (Ripretinib, DCC2618) is a potent, oral inhibitor of singly and doubly mutated KIT with IC50 of WT (IC50=4 nM), V654A (8 nM), T670I (18 nM), D816H (5 nM).
